As of March 23, 2026, the three largest insider holders of CVRX are Johnson Johnson (TenPercentOwner, 4.04Mn shares), Enterprise Associates 10 L P New (TenPercentOwner, 2.03Mn shares), Kirk G. Nielsen (Director, 1.91Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Johnson Johnson | 0 | 4,040,861 | 01 Dec, 2025 | |
| Enterprise Associates 10 L P New | 2,026,083 | 0 | 07 Jul, 2021 | |
| Kirk G. Nielsen | 0 | 1,910,134 | 19 May, 2025 | |
| Geoffrey B Pardo | 0 | 1,829,022 | 02 Jul, 2021 | |
| Plc Glaxosmithkline | 0 | 1,007,583 | 06 Jul, 2021 | |
| Mudit K. Jain | 0 | 980,183 | 23 Feb, 2026 | |
| Kevin Hykes | Pres Ceo | 284,237 | 0 | 03 Mar, 2026 |
| Partners 10 L P Nea | 0 | 173,388 | 07 Jul, 2021 | |
| Jared Oasheim | Chief Financial Officer | 96,703 | 0 | 03 Mar, 2026 |
| Robert Allen John | Chief Revenue Officer | 86,036 | 0 | 03 Mar, 2026 |
| Philip B. Adamson | Chief Medical Officer | 61,578 | 0 | 16 Mar, 2026 |
| Paul Verrastro | Chief Mktg Strat Officer | 60,551 | 0 | 03 Mar, 2026 |
| Dean Bruhn-Ding | Vp Of Reg. Affairs And Qa | 54,648 | 0 | 10 Feb, 2022 |
| Gregory Morrison | Chief Human Resources Officer | 34,000 | 0 | 04 Mar, 2026 |
| Brent Binkowski | Chief Operating Officer | 31,600 | 0 | 03 Mar, 2026 |
| Joseph P Slattery | 30,645 | 0 | 15 Aug, 2024 | |
| John M Nehra | 28,266 | 100 | 02 Jul, 2021 | |
| Nadim Yared | Chief Executive Officer | 26,255 | 0 | 31 Jan, 2024 |
| John Brintnall | Chief Strategy Officer And Sec | 21,901 | 0 | 26 Apr, 2022 |
| Philip B. Adamson | Chief Medical Officer | 20,000 | 0 | 04 Mar, 2025 |
| Mudit K. Jain | 5,650 | 0 | 18 Feb, 2026 | |
| Craig E. Palmer | Svp, U.S. Sales | 1,229 | 0 | 27 Mar, 2024 |
| Liz Galle | Vp Of Global Clinical Research | 778 | 0 | 18 Oct, 2023 |
| Ali Behbahani | 316 | 0 | 18 Dec, 2023 | |
| Ali Behbahani | 316 | 0 | 18 Dec, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 27 Feb, 2026 | Philip B. Adamson | Common Stock | A | 41,000 | $0.00 | 62,840 | D | A |
| 02 Mar, 2026 | Philip B. Adamson | Common Stock | D | 1,262 | $7.90 | 61,578 | D | S |
| 27 Feb, 2026 | Philip B. Adamson | Stock Option (right to buy) | A | 62,000 | $0.00 | 62,000 | D | A |
| 02 Mar, 2026 | Gregory Morrison | Common Stock | A | 34,000 | $0.00 | 34,000 | D | A |
| 02 Mar, 2026 | Gregory Morrison | Stock Option (right to buy) | A | 154,500 | $0.00 | 154,500 | D | A |
| 27 Feb, 2026 | Jared Oasheim | Common Stock | A | 61,000 | $0.00 | 98,447 | D | A |
| 27 Feb, 2026 | Paul Verrastro | Common Stock | A | 45,000 | $0.00 | 61,835 | D | A |
| 27 Feb, 2026 | Robert Allen John | Common Stock | A | 35,000 | $0.00 | 90,000 | D | A |
| 27 Feb, 2026 | Brent Binkowski | Common Stock | A | 15,000 | $0.00 | 31,600 | D | A |
| 27 Feb, 2026 | Kevin Hykes | Common Stock | A | 159,000 | $0.00 | 292,000 | D | A |
| 02 Mar, 2026 | Kevin Hykes | Common Stock | D | 7,763 | $7.90 | 284,237 | D | S |
| 02 Mar, 2026 | Paul Verrastro | Common Stock | D | 1,284 | $7.90 | 60,551 | D | S |
| 02 Mar, 2026 | Robert Allen John | Common Stock | D | 3,964 | $7.90 | 86,036 | D | S |
| 02 Mar, 2026 | Jared Oasheim | Common Stock | D | 1,744 | $7.90 | 96,703 | D | S |
| 27 Feb, 2026 | Brent Binkowski | Stock Option (right to buy) | A | 23,000 | $0.00 | 23,000 | D | A |
| 27 Feb, 2026 | Robert Allen John | Stock Option (right to buy) | A | 52,000 | $0.00 | 52,000 | D | A |
| 27 Feb, 2026 | Paul Verrastro | Stock Option (right to buy) | A | 67,000 | $0.00 | 67,000 | D | A |
| 27 Feb, 2026 | Jared Oasheim | Stock Option (right to buy) | A | 91,000 | $0.00 | 91,000 | D | A |
| 27 Feb, 2026 | Kevin Hykes | Stock Option (right to buy) | A | 238,000 | $0.00 | 238,000 | D | A |
| 20 Feb, 2026 | Mudit K. Jain | Common Stock | A | 46,800 | $6.36 | 980,183 | I | P |